Global PD-L1 and PIK3CA Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of PD-L1 and PIK3CA Testing by Type
- 1.3.1 Overview: Global PD-L1 and PIK3CA Testing Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global PD-L1 and PIK3CA Testing Consumption Value Market Share by Type in 2023
- 1.3.3 PD-L1 Testing
- 1.3.4 PIK3CA Testing
- 1.4 Global PD-L1 and PIK3CA Testing Market by Application
- 1.4.1 Overview: Global PD-L1 and PIK3CA Testing Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital
- 1.4.3 Diagnostic Center
- 1.4.4 Others
- 1.5 Global PD-L1 and PIK3CA Testing Market Size & Forecast
- 1.6 Global PD-L1 and PIK3CA Testing Market Size and Forecast by Region
- 1.6.1 Global PD-L1 and PIK3CA Testing Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global PD-L1 and PIK3CA Testing Market Size by Region, (2019-2030)
- 1.6.3 North America PD-L1 and PIK3CA Testing Market Size and Prospect (2019-2030)
- 1.6.4 Europe PD-L1 and PIK3CA Testing Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific PD-L1 and PIK3CA Testing Market Size and Prospect (2019-2030)
- 1.6.6 South America PD-L1 and PIK3CA Testing Market Size and Prospect (2019-2030)
- 1.6.7 Middle East & Africa PD-L1 and PIK3CA Testing Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Agilent Technologies
- 2.1.1 Agilent Technologies Details
- 2.1.2 Agilent Technologies Major Business
- 2.1.3 Agilent Technologies PD-L1 and PIK3CA Testing Product and Solutions
- 2.1.4 Agilent Technologies PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Agilent Technologies Recent Developments and Future Plans
- 2.2 Roche
- 2.2.1 Roche Details
- 2.2.2 Roche Major Business
- 2.2.3 Roche PD-L1 and PIK3CA Testing Product and Solutions
- 2.2.4 Roche PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Roche Recent Developments and Future Plans
- 2.3 QIAGEN
- 2.3.1 QIAGEN Details
- 2.3.2 QIAGEN Major Business
- 2.3.3 QIAGEN PD-L1 and PIK3CA Testing Product and Solutions
- 2.3.4 QIAGEN PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 QIAGEN Recent Developments and Future Plans
- 2.4 EntroGen
- 2.4.1 EntroGen Details
- 2.4.2 EntroGen Major Business
- 2.4.3 EntroGen PD-L1 and PIK3CA Testing Product and Solutions
- 2.4.4 EntroGen PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 EntroGen Recent Developments and Future Plans
- 2.5 Amoy Diagnostics
- 2.5.1 Amoy Diagnostics Details
- 2.5.2 Amoy Diagnostics Major Business
- 2.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Product and Solutions
- 2.5.4 Amoy Diagnostics PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Amoy Diagnostics Recent Developments and Future Plans
- 2.6 ACCB Biotech
- 2.6.1 ACCB Biotech Details
- 2.6.2 ACCB Biotech Major Business
- 2.6.3 ACCB Biotech PD-L1 and PIK3CA Testing Product and Solutions
- 2.6.4 ACCB Biotech PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 ACCB Biotech Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global PD-L1 and PIK3CA Testing Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of PD-L1 and PIK3CA Testing by Company Revenue
- 3.2.2 Top 3 PD-L1 and PIK3CA Testing Players Market Share in 2023
- 3.2.3 Top 6 PD-L1 and PIK3CA Testing Players Market Share in 2023
- 3.3 PD-L1 and PIK3CA Testing Market: Overall Company Footprint Analysis
- 3.3.1 PD-L1 and PIK3CA Testing Market: Region Footprint
- 3.3.2 PD-L1 and PIK3CA Testing Market: Company Product Type Footprint
- 3.3.3 PD-L1 and PIK3CA Testing Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global PD-L1 and PIK3CA Testing Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global PD-L1 and PIK3CA Testing Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global PD-L1 and PIK3CA Testing Consumption Value Market Share by Application (2019-2024)
- 5.2 Global PD-L1 and PIK3CA Testing Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America PD-L1 and PIK3CA Testing Consumption Value by Type (2019-2030)
- 6.2 North America PD-L1 and PIK3CA Testing Market Size by Application (2019-2030)
- 6.3 North America PD-L1 and PIK3CA Testing Market Size by Country
- 6.3.1 North America PD-L1 and PIK3CA Testing Consumption Value by Country (2019-2030)
- 6.3.2 United States PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
- 6.3.3 Canada PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
- 6.3.4 Mexico PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe PD-L1 and PIK3CA Testing Consumption Value by Type (2019-2030)
- 7.2 Europe PD-L1 and PIK3CA Testing Consumption Value by Application (2019-2030)
- 7.3 Europe PD-L1 and PIK3CA Testing Market Size by Country
- 7.3.1 Europe PD-L1 and PIK3CA Testing Consumption Value by Country (2019-2030)
- 7.3.2 Germany PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
- 7.3.3 France PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
- 7.3.5 Russia PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
- 7.3.6 Italy PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific PD-L1 and PIK3CA Testing Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific PD-L1 and PIK3CA Testing Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region
- 8.3.1 Asia-Pacific PD-L1 and PIK3CA Testing Consumption Value by Region (2019-2030)
- 8.3.2 China PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
- 8.3.3 Japan PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
- 8.3.4 South Korea PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
- 8.3.5 India PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
- 8.3.7 Australia PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America PD-L1 and PIK3CA Testing Consumption Value by Type (2019-2030)
- 9.2 South America PD-L1 and PIK3CA Testing Consumption Value by Application (2019-2030)
- 9.3 South America PD-L1 and PIK3CA Testing Market Size by Country
- 9.3.1 South America PD-L1 and PIK3CA Testing Consumption Value by Country (2019-2030)
- 9.3.2 Brazil PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
- 9.3.3 Argentina PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa PD-L1 and PIK3CA Testing Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa PD-L1 and PIK3CA Testing Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country
- 10.3.1 Middle East & Africa PD-L1 and PIK3CA Testing Consumption Value by Country (2019-2030)
- 10.3.2 Turkey PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
- 10.3.4 UAE PD-L1 and PIK3CA Testing Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 PD-L1 and PIK3CA Testing Market Drivers
- 11.2 PD-L1 and PIK3CA Testing Market Restraints
- 11.3 PD-L1 and PIK3CA Testing Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 PD-L1 and PIK3CA Testing Industry Chain
- 12.2 PD-L1 and PIK3CA Testing Upstream Analysis
- 12.3 PD-L1 and PIK3CA Testing Midstream Analysis
- 12.4 PD-L1 and PIK3CA Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.
PIK3CA is a gene that encodes a lipid kinase involved in multiple signaling pathways. These pathways influence cellular functions such as growth, death, and proliferation. PIK3CA mutations activate the PI3K-PTEN-AKT pathway, which is downstream from both the EGFR and the RAS-RAF-MAPK pathways. PIK3CA mutations may cause oncogenic transformation independent of RAS or RAF mutations.
PIK3CA mutations occur in about 15% to 30% of breast, endometrial, and colon cancers. They occur less frequently in lung cancer and other types of cancer. Presence of PIK3CA mutations is associated with poor prognosis and lack of response to specific therapies in patients with breast, endometrial, or colon cancer.
According to our (Global Info Research) latest study, the global PD-L1 and PIK3CA Testing market size was valued at US$ 657 million in 2023 and is forecast to a readjusted size of USD 2339 million by 2030 with a CAGR of 20.1% during review period.
The classification of PD-L1 and PIK3CA Testing Product includes PD-L1 Testing and PIK3CA Testing. PD-L1 accounted for a share of 80% in the global PD-L1 and PIK3CA Testing Product market.
PD-L1 and PIK3CA Testing Product is widely used in Hospital, Diagnostic Center and Other. In PD-L1 and PIK3CA Testing Product market, the Diagnostic Center holds an important share in terms of Application.
North America is the largest consumption place, with a market share nearly 57% . Following North America, Europe is the second largest consumption place with the market share of 28%.
Market competition is intense. Agilent Technologies, Roche, QIAGEN, Amoy Diagnostics, ACCB Biotech, etc. The top five vendors held 84% of the market share.
This report is a detailed and comprehensive analysis for global PD-L1 and PIK3CA Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global PD-L1 and PIK3CA Testing market size and forecasts, in consumption value ($ Million), 2019-2030
Global PD-L1 and PIK3CA Testing market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global PD-L1 and PIK3CA Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global PD-L1 and PIK3CA Testing market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PD-L1 and PIK3CA Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global PD-L1 and PIK3CA Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Roche, QIAGEN, EntroGen, Amoy Diagnostics, ACCB Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
PD-L1 and PIK3CA Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
PD-L1 and PIK3CA Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
PD-L1 Testing
PIK3CA Testing
Market segment by Application
Hospital
Diagnostic Center
Others
Market segment by players, this report covers
Agilent Technologies
Roche
QIAGEN
EntroGen
Amoy Diagnostics
ACCB Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe PD-L1 and PIK3CA Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of PD-L1 and PIK3CA Testing, with revenue, gross margin, and global market share of PD-L1 and PIK3CA Testing from 2019 to 2024.
Chapter 3, the PD-L1 and PIK3CA Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and PD-L1 and PIK3CA Testing market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of PD-L1 and PIK3CA Testing.
Chapter 13, to describe PD-L1 and PIK3CA Testing research findings and conclusion.